Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bipolar Disorder01:30

Bipolar Disorder

Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring psychosocial interventions for adults involuntarily admitted to psychiatric inpatient settings: a scoping review.

Journal of mental health (Abingdon, England)·2026
Same author

Stressful life events and their association with symptom severity and functioning in first-episode psychosis.

Schizophrenia (Heidelberg, Germany)·2026
Same author

Longitudinal brain structural changes during clozapine treatment: associations with neuroreceptor architecture and clinical response.

medRxiv : the preprint server for health sciences·2026
Same author

Co-expression-based models improve eQTL predictions for transcriptome-wide association studies and highlight new schizophrenia-associated genes.

Nature genetics·2026
Same author

White matter microstructure in relatives of people with schizophrenia or bipolar disorder: an ENIGMA meta-analysis.

Molecular psychiatry·2026
Same author

ACKR1/Duffy-null genotype testing for clozapine: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx).

British journal of clinical pharmacology·2026
Same journal

Effectiveness and safety of repeat dose subcutaneous ketamine for treatment-resistant depression, and the impact of prior ketamine treatment: open label extension of the KADS study.

The British journal of psychiatry : the journal of mental science·2026
Same journal

Definitional invisibility: when institutional language reframes identity as choice.

The British journal of psychiatry : the journal of mental science·2026
Same journal

Potential implications of removing evidence of impairment from the DSM-5 age-of-onset criterion in adult ADHD assessment.

The British journal of psychiatry : the journal of mental science·2026
Same journal

The pressurised leaky funnel: rethinking recruitment, selection and retention in the UK psychiatry workforce.

The British journal of psychiatry : the journal of mental science·2026
Same journal

Cutting through stigma: psychiatry and neurosurgery working together.

The British journal of psychiatry : the journal of mental science·2026
Same journal

A fourth pillar for evidence-based medicine: implications for psychiatry - CORRIGENDUM.

The British journal of psychiatry : the journal of mental science·2026
See all related articles

Related Experiment Video

Updated: Jun 25, 2026

Examining Bilingual Language Control Using the Stroop Task
05:31

Examining Bilingual Language Control Using the Stroop Task

Published on: February 26, 2020

Stroop-test interference in bipolar disorder.

Eugenia Kravariti1, Katja Schulze, Fergus Kane

  • 1Institute of Psychiatry, King's College London, De Crespigny Park, London SE5 8AF, UK. e.kravariti@iop.kcl.ac.uk

The British Journal of Psychiatry : the Journal of Mental Science
|March 3, 2009
PubMed
Summary
This summary is machine-generated.

Individuals with bipolar disorder exhibit impaired response inhibition on the Stroop test. However, their first-degree relatives show normal performance, indicating no increased susceptibility to interference in this study.

More Related Videos

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
07:42

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

The Emotional Stroop Task: Assessing Cognitive Performance under Exposure to Emotional Content
07:21

The Emotional Stroop Task: Assessing Cognitive Performance under Exposure to Emotional Content

Published on: June 29, 2016

Related Experiment Videos

Last Updated: Jun 25, 2026

Examining Bilingual Language Control Using the Stroop Task
05:31

Examining Bilingual Language Control Using the Stroop Task

Published on: February 26, 2020

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
07:42

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

The Emotional Stroop Task: Assessing Cognitive Performance under Exposure to Emotional Content
07:21

The Emotional Stroop Task: Assessing Cognitive Performance under Exposure to Emotional Content

Published on: June 29, 2016

Area of Science:

  • Neuroscience
  • Psychiatry
  • Genetics

Background:

  • Bipolar disorder is a complex mental health condition.
  • Response inhibition is a key cognitive function.
  • Understanding genetic and environmental factors in bipolar disorder is crucial.

Purpose of the Study:

  • To investigate response inhibition deficits in bipolar I disorder.
  • To examine cognitive performance in first-degree relatives of individuals with bipolar disorder.
  • To explore the association between Stroop performance and depressive symptoms.

Main Methods:

  • Utilized the Stroop neuropsychological screening test.
  • Compared individuals with bipolar I disorder (twin pairs and singletons) with healthy controls.
  • Assessed first-degree relatives of bipolar disorder patients.

Main Results:

  • Individuals with bipolar disorder demonstrated significant deficits in response inhibition (Stroop interference).
  • First-degree relatives of bipolar disorder patients exhibited intact performance on the Stroop test.
  • In bipolar I disorder patients, higher interference scores correlated with increased depressive symptoms.

Conclusions:

  • Response inhibition deficits are present in bipolar I disorder.
  • Familial risk for bipolar disorder does not appear to confer heightened susceptibility to Stroop interference.
  • Depressive symptoms may influence response inhibition in bipolar disorder patients.